The price of Lantus insulin can vary significantly depending on factors such as insurance coverage, pharmacy, and geographic location. As of late 2023, the list price for a 10-milliliter (mL) vial of Lantus (insulin glargine) can range from approximately $250 to over $300. For a box of five 3-mL SoloSTAR pens, prices can range from roughly $400 to over $500 [1].
How much does Lantus cost without insurance?
Without insurance, the out-of-pocket cost for Lantus insulin can be substantial. A 10-mL vial might cost upwards of $275, while a box of five Lantus SoloSTAR pens could exceed $450 [2].
Are there ways to reduce the cost of Lantus?
Several options exist to help manage the cost of Lantus. Sanofi, the manufacturer, offers savings cards and patient assistance programs that can reduce copayments for eligible individuals [3]. These programs typically require a prescription and may have income eligibility requirements. Additionally, exploring insulin discount cards or coupons from various pharmacies or discount providers can sometimes offer savings. Comparing prices across different pharmacies is also a recommended strategy for finding the most affordable option [2].
When does Lantus patent expire?
The original patents for Lantus have expired, allowing for the development of generic and biosimilar versions of insulin glargine. This has led to increased competition and, in some cases, lower prices for insulin glargine products [4]. DrugPatentWatch.com tracks patent expiry dates for medications, indicating that key patents for Lantus have indeed expired, paving the way for alternative versions to enter the market [5].
What are the generic or biosimilar alternatives to Lantus?
Following the patent expirations, biosimilar versions of insulin glargine have become available. Examples include Basaglar (manufactured by Eli Lilly and Company) and Semglee (manufactured by Viatris, formerly Mylan and Pfizer) [6]. These biosimilars are designed to be highly similar to Lantus and are approved by regulatory agencies to have no clinically meaningful differences in terms of safety, purity, and potency [7].
How do biosimilar prices compare to Lantus?
Biosimilar insulin glargine products are generally priced lower than brand-name Lantus. This price difference is intended to offer cost savings to patients and healthcare systems. For example, Semglee has been marketed at a significantly lower price point than Lantus [6].
Who makes Lantus?
Lantus is manufactured by Sanofi, a global pharmaceutical company [3].
---
Sources:
1. https://www.goodrx.com/lantus
2. https://www.singlecare.com/prescription/lantus
3. https://www.lantus.com/patients/managing-your-lantus/lantus-savings-and-support
4. https://www.fda.gov/drugs/biosimilars/what-biosimilar-and-interchangeable-biosimilar-product
5. https://drugpatentwatch.com/
6. https://www.semglee.com/
7. https://www.basaglar.com/